We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Fields »
 

Field

Term
Gene name

Class

Subclass

Chromosome

External id

In atlas

Reliability

Reliability

Reliability

Validation

Method

Validation

Method

Validation

Method

Validation

Location

Searches

Tissue

Cell type

Expression

Tissue

Specificity

Cell line

Specificity

Cancer

Specificity

Tissue

Detectable

Cell line

Detectable

Cancer

Detectable

Cancer

Prognosis

Category

Score

Score

Score

Antibodies

Column

 
 
ABOUT
HELP
BLOG
  • THE HUMAN PROTEOME
  • THE HUMAN TISSUES
  • THE HUMAN CELL
  • HUMAN PATHOLOGY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
    • NEWS
    • BLOG
    • EVENTS
    • PRESS ROOM
    • LEARN
    • DICTIONARY
    • METHODS
    • CELL LINES
  • THE PROJECT
  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • PUBLICATION DATA
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • LINKS
  • CONTACT
  • TECHNICAL DATA
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • DOWNLOADABLE DATA
  • HELP & FAQ
  • LICENCE & CITATION
  • PRIVACY STATEMENT
  • RELEASE HISTORY
PRDX5
  • premium

    TISSUE

  • premium

    CELL

  • PATHOLOGY

PATHOLOGY ATLAS

GENE/PROTEIN

Antibody validation

Dictionary

Level of antibody staining/expression





High
Medium
Low
Not detected

GENERAL INFORMATION

Gene name

PRDX5

Gene description

Peroxiredoxin 5

Protein class

Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins

Predicted localization

Intracellular

Number of transcripts

3
SHOW MORE

HUMAN PROTEIN ATLAS INFORMATION

RNA category

TCGA (cancer tissue):Expressed in all
HPA (cell line):Expressed in all
HPA (normal tissue):Expressed in all

Protein evidence

Evidence at protein level

Protein expression
normal tissue

General cytoplasmic expression, highly abundant in most glandular cells.

ANTIBODY IHC RELIABILITY

Data reliability
description

Antibody staining consistent with RNA expression data.

Reliability score

Supported based on 3 antibodies.
HPA037915 , HPA037916 , CAB008661
SHOW MORE

PROGNOSTIC SUMMARY

Prognostic marker in renal cancer (favourable).
Renal cancer p<0.001
Show all

RNA EXPRESSION OVERVIEW

TCGA dataset
RNA cancer category: Expressed in all

PROTEIN EXPRESSION

Colorectal cancer
Breast cancer
Prostate cancer
Lung cancer
Liver cancer

STAINING SUMMARY

HPA037915
HPA037916
CAB008661

Cancer

Cancer staining

Protein
expression of
normal tissue

Breast cancer
 
Carcinoid
 
Cervical cancer
 
 
Colorectal cancer
 
 
Endometrial cancer
 
 
Glioma
 
Head and neck cancer
 
 
Liver cancer
 
 
Lung cancer
 
 
Lymphoma
 
 
 

Cancer

Cancer staining

Protein
expression of
normal tissue

Melanoma
 
Ovarian cancer
 
Pancreatic cancer
 
Prostate cancer
 
Renal cancer
 
Skin cancer
 
Stomach cancer
 
 
Testis cancer
 
Thyroid cancer
 
Urothelial cancer
 

Staining summary

Cancer cells generally displayed weak to moderate cytoplasmic positivity. Many cases of thyroid cancers were distinctly stained. Several cases of lymphomas, skin and testicular cancers were negative.

Cancer

Cancer staining

Protein
expression of
normal tissue

Breast cancer
 
Carcinoid
 
Cervical cancer
 
 
Colorectal cancer
 
 
Endometrial cancer
 
 
Glioma
 
Head and neck cancer
 
 
Liver cancer
 
 
Lung cancer
 
 
Lymphoma
 
 
 

Cancer

Cancer staining

Protein
expression of
normal tissue

Melanoma
 
Ovarian cancer
 
Pancreatic cancer
 
Prostate cancer
 
Renal cancer
 
Skin cancer
 
Stomach cancer
 
 
Testis cancer
 
Thyroid cancer
 
Urothelial cancer
 

Staining summary

Most cancers displayed weak to moderate cytoplasmic staining. Papillary adenocarcinomas of thyroid showed strong staining. Several lymphomas and testicular cancers were negative.

Cancer

Cancer staining

Protein
expression of
normal tissue

Breast cancer
 
Carcinoid
 
Cervical cancer
 
 
Colorectal cancer
 
 
Endometrial cancer
 
 
Glioma
 
Head and neck cancer
 
 
Liver cancer
 
 
Lung cancer
 
 
Lymphoma
 
 
 

Cancer

Cancer staining

Protein
expression of
normal tissue

Melanoma
 
Ovarian cancer
 
Pancreatic cancer
 
Prostate cancer
 
Renal cancer
 
Skin cancer
 
Stomach cancer
 
 
Testis cancer
 
Thyroid cancer
 
Urothelial cancer
 

Staining summary

Most cancer cells showed weak to moderate cytoplasmic staining. A few cases of colorectal and thyroid cancers showed strong cytoplasmic staining.

GENE INFORMATION

Gene name

PRDX5 (HGNC Symbol)

Synonyms

ACR1, AOEB166, B166, MGC117264, MGC142283, MGC142285, PLP, PMP20, PRDX6, PRXV, SBBI10

Description

Peroxiredoxin 5 (HGNC Symbol)

Entrez gene summary

This gene encodes a member of the peroxiredoxin family of antioxidant enzymes, which reduce hydrogen peroxide and alkyl hydroperoxides. The encoded protein may play an antioxidant protective role in different tissues under normal conditions and during inflammatory processes. This protein interacts with peroxisome receptor 1. The crystal structure of this protein in its reduced form has been resolved to 1.5 angstrom resolution. This gene uses alternate in-frame translation initiation sites to generate mitochondrial or peroxisomal/cytoplasmic forms. Three transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]

Chromosome

11

Cytoband

q13.1

Chromosome location (bp)

64318088 - 64321811

Protein evidence

Evidence at protein level (all genes)

Ensembl

ENSG00000126432 (version 83.38)

Entrez gene

25824

UniProt

P30044 (UniProt - Evidence at protein level)

neXtProt

NX_P30044

Antibodypedia

PRDX5 antibodies

PROTEIN BROWSER

PRDX5-001
PRDX5-002
PRDX5-003

PROTEIN INFORMATION

Splice variant

UniProt

Protein class

Gene ontology

Length & mass

Signal peptide
(predicted)

Transmembrane regions
(predicted)

PRDX5-001
ENSP00000265462
ENST00000265462
P30044 [Direct mapping]
Peroxiredoxin-5, mitochondrial
Show all
Enzymes
   ENZYME proteins
   Oxidoreductases
   SPOCTOPUS predicted secreted proteins
Predicted intracellular proteins
Plasma proteins
FDA approved drug targets
   Small molecule drugs
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000302 [response to reactive oxygen species]
GO:0001016 [RNA polymerase III regulatory region DNA binding]
GO:0004601 [peroxidase activity]
GO:0005102 [receptor binding]
GO:0005615 [extracellular space]
GO:0005634 [nucleus]
GO:0005737 [cytoplasm]
GO:0005739 [mitochondrion]
GO:0005759 [mitochondrial matrix]
GO:0005777 [peroxisome]
GO:0005782 [peroxisomal matrix]
GO:0005829 [cytosol]
GO:0006367 [transcription initiation from RNA polymerase II promoter]
GO:0006915 [apoptotic process]
GO:0006954 [inflammatory response]
GO:0006979 [response to oxidative stress]
GO:0010467 [gene expression]
GO:0016209 [antioxidant activity]
GO:0016480 [negative regulation of transcription from RNA polymerase III promoter]
GO:0016491 [oxidoreductase activity]
GO:0031410 [cytoplasmic vesicle]
GO:0032967 [positive regulation of collagen biosynthetic process]
GO:0034614 [cellular response to reactive oxygen species]
GO:0042744 [hydrogen peroxide catabolic process]
GO:0043027 [cysteine-type endopeptidase inhibitor activity involved in apoptotic process]
GO:0043066 [negative regulation of apoptotic process]
GO:0043154 [negative regulation of cysteine-type endopeptidase activity involved in apoptotic process]
GO:0043231 [intracellular membrane-bounded organelle]
GO:0046983 [protein dimerization activity]
GO:0048471 [perinuclear region of cytoplasm]
GO:0051354 [negative regulation of oxidoreductase activity]
GO:0051920 [peroxiredoxin activity]
GO:0055114 [oxidation-reduction process]
GO:0060785 [regulation of apoptosis involved in tissue homeostasis]
GO:0070062 [extracellular exosome]
GO:0070995 [NADPH oxidation]
GO:0072541 [peroxynitrite reductase activity]
GO:2001057 [reactive nitrogen species metabolic process]
Show all
214 aa
22.1 kDa
No 0
PRDX5-002
ENSP00000335334
ENST00000352435
P30044 [Direct mapping]
Peroxiredoxin-5, mitochondrial
Show all
Enzymes
   ENZYME proteins
   Oxidoreductases
   SPOCTOPUS predicted secreted proteins
Predicted intracellular proteins
Plasma proteins
FDA approved drug targets
   Small molecule drugs
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000302 [response to reactive oxygen species]
GO:0001016 [RNA polymerase III regulatory region DNA binding]
GO:0004601 [peroxidase activity]
GO:0005102 [receptor binding]
GO:0005615 [extracellular space]
GO:0005634 [nucleus]
GO:0005737 [cytoplasm]
GO:0005739 [mitochondrion]
GO:0005759 [mitochondrial matrix]
GO:0005777 [peroxisome]
GO:0005782 [peroxisomal matrix]
GO:0005829 [cytosol]
GO:0006367 [transcription initiation from RNA polymerase II promoter]
GO:0006915 [apoptotic process]
GO:0006954 [inflammatory response]
GO:0006979 [response to oxidative stress]
GO:0010467 [gene expression]
GO:0016209 [antioxidant activity]
GO:0016480 [negative regulation of transcription from RNA polymerase III promoter]
GO:0016491 [oxidoreductase activity]
GO:0031410 [cytoplasmic vesicle]
GO:0032967 [positive regulation of collagen biosynthetic process]
GO:0034614 [cellular response to reactive oxygen species]
GO:0042744 [hydrogen peroxide catabolic process]
GO:0043027 [cysteine-type endopeptidase inhibitor activity involved in apoptotic process]
GO:0043066 [negative regulation of apoptotic process]
GO:0043154 [negative regulation of cysteine-type endopeptidase activity involved in apoptotic process]
GO:0043231 [intracellular membrane-bounded organelle]
GO:0046983 [protein dimerization activity]
GO:0048471 [perinuclear region of cytoplasm]
GO:0051354 [negative regulation of oxidoreductase activity]
GO:0051920 [peroxiredoxin activity]
GO:0055114 [oxidation-reduction process]
GO:0060785 [regulation of apoptosis involved in tissue homeostasis]
GO:0070062 [extracellular exosome]
GO:0070995 [NADPH oxidation]
GO:0072541 [peroxynitrite reductase activity]
GO:2001057 [reactive nitrogen species metabolic process]
Show all
170 aa
17.5 kDa
No 0
PRDX5-003
ENSP00000335363
ENST00000347941
P30044 [Direct mapping]
Peroxiredoxin-5, mitochondrial
Show all
Enzymes
   ENZYME proteins
   Oxidoreductases
   SPOCTOPUS predicted secreted proteins
Predicted intracellular proteins
Plasma proteins
FDA approved drug targets
   Small molecule drugs
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000302 [response to reactive oxygen species]
GO:0001016 [RNA polymerase III regulatory region DNA binding]
GO:0004601 [peroxidase activity]
GO:0005102 [receptor binding]
GO:0005615 [extracellular space]
GO:0005634 [nucleus]
GO:0005737 [cytoplasm]
GO:0005739 [mitochondrion]
GO:0005759 [mitochondrial matrix]
GO:0005777 [peroxisome]
GO:0005782 [peroxisomal matrix]
GO:0005829 [cytosol]
GO:0006367 [transcription initiation from RNA polymerase II promoter]
GO:0006915 [apoptotic process]
GO:0006954 [inflammatory response]
GO:0006979 [response to oxidative stress]
GO:0010467 [gene expression]
GO:0016209 [antioxidant activity]
GO:0016480 [negative regulation of transcription from RNA polymerase III promoter]
GO:0016491 [oxidoreductase activity]
GO:0031410 [cytoplasmic vesicle]
GO:0032967 [positive regulation of collagen biosynthetic process]
GO:0034614 [cellular response to reactive oxygen species]
GO:0042744 [hydrogen peroxide catabolic process]
GO:0043027 [cysteine-type endopeptidase inhibitor activity involved in apoptotic process]
GO:0043066 [negative regulation of apoptotic process]
GO:0043154 [negative regulation of cysteine-type endopeptidase activity involved in apoptotic process]
GO:0043231 [intracellular membrane-bounded organelle]
GO:0046983 [protein dimerization activity]
GO:0048471 [perinuclear region of cytoplasm]
GO:0051354 [negative regulation of oxidoreductase activity]
GO:0051920 [peroxiredoxin activity]
GO:0055114 [oxidation-reduction process]
GO:0060785 [regulation of apoptosis involved in tissue homeostasis]
GO:0070062 [extracellular exosome]
GO:0070995 [NADPH oxidation]
GO:0072541 [peroxynitrite reductase activity]
GO:2001057 [reactive nitrogen species metabolic process]
Show all
125 aa
12.9 kDa
No 0

Contact

  • BLOG
  • PRESS ROOM
  • contact@proteinatlas.org

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • DOWNLOADABLE DATA

The Human Protein Atlas

  • ANTIBODY AVAILABILITY
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.